combretastatin has been researched along with camptothecin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coy, DH; Fuselier, JA; Murphy, WA; Sun, L; Vasilevich, N; Woltering, SN | 1 |
Coy, DH; Franko-Tobin, LG; Fuselier, JA; LePage, KT; Leslie, JS; Luo, J; Mackey, LV; Morris, LM; Sun, L | 1 |
Chen, M; Li, X; Luo, X; Wei, J; Xu, G; Zhang, H | 1 |
Huang, YC; Lee, WH; Liu, SC; Liu, SJ; Su, CH; Tseng, YY; Wang, YC; Yang, ST | 1 |
4 other study(ies) available for combretastatin and camptothecin
Article | Year |
---|---|
An adjustable release rate linking strategy for cytotoxin-peptide conjugates.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; Bibenzyls; Camptothecin; Carbamates; Cross-Linking Reagents; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Neuroblastoma; Peptides; Rats; Somatostatin; Stilbenes; Structure-Activity Relationship; Tumor Cells, Cultured | 2003 |
Application of human pancreatic carcinoid BON cells for receptor-targeted drug development.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bibenzyls; Bombesin; Camptothecin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; Drug Design; Humans; Ligands; Mice; Mice, Nude; Molecular Targeted Therapy; Pancreatic Neoplasms; Protein Binding; Real-Time Polymerase Chain Reaction; Receptors, Bombesin; Receptors, Cell Surface; Receptors, Somatostatin; Somatostatin; Xenograft Model Antitumor Assays | 2011 |
Tunable release of chemotherapeutic and vascular disrupting agents from injectable fiber fragments potentiates combination chemotherapy.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; beta-Cyclodextrins; Bibenzyls; Camptothecin; Cell Line, Tumor; Cell Proliferation; Drug Liberation; Drug Therapy, Combination; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred BALB C; Neoplasms; Tumor Microenvironment | 2016 |
Advanced interstitial chemotherapy combined with targeted treatment of malignant glioma in rats by using drug-loaded nanofibrous membranes.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bibenzyls; Brain; Brain Neoplasms; Camptothecin; Cisplatin; Disease Models, Animal; Drug Delivery Systems; Ethylnitrosourea; Glioblastoma; Glioma; Humans; Irinotecan; Lactic Acid; Male; Nanofibers; Neurosurgical Procedures; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Tumor Burden | 2016 |